
|Articles|July 1, 2005
More unhealthy news for the drug biz
Advertisement
These aren't happy times for the pharmaceutical industry. Day by day, bad news accumulates, and even the Pharmaceutical Research and Manufacturers Association (PhRMA), the industry's trade organization, acknowledges that something has to give:
Newsletter
Access practical, evidence-based guidance to support better care for our youngest patients. Join our email list for the latest clinical updates.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contemporary Pediatrics
1
Weekly review: Centanafadine NDA, gene therapy approval, and more
2
Navepegritide demonstrates growth velocity, skeletal alignment in children with achondroplasia
3
First patient dosed in trial of EN-374 to treat X-linked chronic granulomatous disease
4
Top 5 pediatric health headlines you missed in November 2025
5










